In a new study, researchers examined herbal supplements with immune-activating properties that could trigger or worsen ...

Phase 3 trial data show subcutaneous anifrolumab improves BICLA response rates and reduces oral corticosteroid use in ...

It's more important than ever before for your elected officials to hear from you - don't miss your chance to turn Capitol ...

Fresh off of a European approval for a subcutaneous version of Saphnelo, AstraZeneca is doubling down on the benefits of the ...

Systemic Lupus Erythematosus is one of the most complex autoimmune diseases seen in modern medicine, affecting multiple organs and presenting differently from one patient to another. Often referred to ...

Lupus is often marked by flares, which is when symptoms are usually more obvious.

Scientists may have pinpointed a primary cause of lupus, a chronic autoimmune disease. Researchers from Northwestern Medicine in Chicago and Brigham and Women’s Hospital in Boston claim they have ...

Lupus is considered a common disease that impacts millions of people worldwide. Until recently, the cause of this disease was unknown. However, in a study released this week, researchers may have made ...

Subcutaneous anifrolumab (Saphnelo) added to standard therapy significantly improves treatment outcomes in patients with ...

ORLANDO, Fla. - Lupus is a debilitating autoimmune disease that affects around 1.5 million Americans. Now, new research shows a therapy that’s been used for cancer patients may help people with lupus ...

Kyleigh MacGregor plans her life five years at a time. MacGregor has lupus, an incurable disease in which her immune system attacks her body’s organs and tissue. It’s been a year since MacGregor, 31, ...

Lupus affects women at disproportionately high rates— roughly 9 out of 10 patients are female —and research consistently ...